MaxCyte President and CEO Maher Masoud reports acquisition of $120,780 in common shares
MXCT•MaxCyte CEO Maher Masoud purchased 100,000 common shares at $1.2078 each, raising his direct beneficial ownership to 575,000 shares.
1. Share purchase
Maher Masoud, MaxCyte’s president and CEO, purchased 100,000 common shares at $1.2078 each. His direct beneficial ownership rose to 575,000 common shares.




